In addition to pulmonary fibrosis, columnist Ann Reynoso is now also dealing with sleep apnea — both of which affect her ...
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Boehringer Ingelheim has ended a decade of industrywide failures in idiopathic pulmonary fibrosis (IPF) by reporting a phase ...
Medical Xpress on MSN22h
Fibrosis lacks treatments and methods of reversal: Study pinpoints a promising target for drug therapy"We sought to identify alternative ways to inhibit TGFβ signaling using human hepatic stellate cells and macrophages from ...
COVID-19 has no impact on body mass index (BMI) trajectory or lung function in people with cystic fibrosis (pwCF) in the year following infection.
Among patients with PPF, those treated with 60 mg of admilparant showed significant decreases in periostin, ferritin, and ...
Boehringer Ingelheim’s investigational compound nerandomilast, which targets the PDE4B enzyme involved in fibrosis and ...
GlobalData on MSN7d
Boehringer seeks approval for lung fibrosis drug following Phase III winThe Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...
News Medical on MSN4d
Anti-fibrotic drug shows promise in breast cancerThe most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of ...
A research group from Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences ...
Verywell Health on MSN1y
What Is Cystic Fibrosis-Related Diabetes (CFRD)?CF is an inherited disorder that causes the mucus in your body to be thick and sticky. It affects many organs and body ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback